Latest Regulatory News

The Takeovers Panel has declined to investigate Skin Elements Limited's allegations of undisclosed investor associations following a $2.5 million placement, after 62 Capital agreed to waive transfer restrictions on placement securities.

Bio-Gene Technology has expanded its capital raise to $2.775 million through a share placement priced at 2.5 cents, attaching options exercisable at 3.5 cents pending shareholder approval.

Scalare Partners has acquired Fishburners, Australia’s largest startup community, to deepen its founder network and expand integrated support services across the country.

Avira Resources has kicked off a 4,500-metre reverse circulation drilling program at its Mt Cattlin Gold Project in Western Australia, aiming to expand known high-grade zones and test new prospects ahead of a maiden resource estimate.

EV Resources has locked in agreements covering more than 50% of its Tecomatlán Processing Plant's feedstock capacity through four non-binding MOUs, advancing its path to near-term antimony production amid global supply tightness.

Resouro Strategic Metals has locked in a binding agreement with Future Mining and Buri Gold to fund and operate mining and processing at its Novo Mundo gold project in Brazil, aiming to generate cash flow without diverting capital from its flagship Tiros project.

Akora Resources has pushed back the deadline for its $1.7 million entitlement offer to 19 June 2026, responding to shareholder feedback and ensuring broader participation.

Imagion Biosystems has secured FDA clearance to proceed with its Phase 1b/2 trial of the MagSense® HER2 Imaging Agent, targeting improved detection of HER2+ breast cancer. Patient recruitment is expected to start in Q3 2026, marking a crucial step toward commercialisation.

Entropy Neurodynamics has successfully dosed all six participants in the first cohort of its Phase 2 trial for TRP-8803, an intravenous psilocin therapy targeting Binge Eating Disorder. The study demonstrated controlled psychedelic responses, setting the stage for a Data and Safety Monitoring Board review and topline results expected in July 2026.

Yugo Metals has secured a $5 million oversubscribed placement to ramp up drilling across its gold, nickel-cobalt, and base metals projects in the Balkans, positioning the company for significant exploration milestones over the next 18 months.

TPG Telecom’s 2026 Investor Day reaffirmed FY26 EBITDA guidance and outlined a medium-term plan focused on mobile revenue growth, digital transformation, and cost efficiency, supported by a robust balance sheet ahead of spectrum licence renewals.

4DMedical launches the CLEAR clinical evidence program to accelerate adoption of its CT:VQ™ imaging technology in the US acute pulmonary embolism market, aiming to expand its addressable market to US$3 billion.